Sensorion Completes Reverse Share Split

Sensorion has successfully completed a reverse share split, where 50 existing shares of €0.10 each are consolidated into 1 new share worth €5. This strategic move was approved following the company's General Shareholders' Meeting in May 2026 and is effective from September 15, 2026. The company's objective is to streamline its share structure.

The reverse share split affects 515,648,600 existing shares, resulting in 10,312,972 new shares, which are now listed on Euronext Growth Market in Paris under the ISIN code FR001401A9Z0. Shareholders with shares not in multiples of 50 will receive compensation from their financial intermediaries. The adjustment process will span from September 17 to October 17, 2026.

Sensorion continues to develop therapies for hearing loss, maintaining its pioneering role in the biotechnology sector with its strong R&D initiatives.